Sabra Health Care price target raised to $19 from $18 at Scotiabank
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SBRA:
Disclaimer & DisclosureReport an Issue
Sabra Health Care REIT Reports Strong Q1 2025 Results
Sabra Healthcare REIT Reports Record Highs and Strong Pipeline
Hold Rating on Sabra Healthcare REIT Amid Strong Financials and Strategic Uncertainties
Sabra Healthcare REIT Expands Senior Housing Portfolio
Sabra Health Care reports Q1 FFO 37c, consensus 36c
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
3 hours ago
- Business Insider
3 'Strong Buy' Value Stocks to Buy Now, 8/13/2025, According to Analysts
Value stocks offer stability for investors by focusing on companies that seem underpriced compared to their actual worth. This approach involves looking for stocks with strong fundamentals and growth potential. By investing in these stocks, investors can achieve significant returns once the market recognizes their true value. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. One way to identify value stocks is by comparing a company's price-to-earnings (P/E) ratio with industry averages or its historical P/E ratios. This ratio compares a company's stock price to its earnings per share. It must be noted that a lower P/E ratio may indicate that the stock is undervalued. Along with this, we have zeroed in on stocks that have received 'Strong Buy' ratings from Wall Street analysts. Here Are This Week's Stocks NICE Ltd. (NICE) – This software company provides cloud and on-premises solutions for customer experience, compliance, and financial crime prevention. It has a Strong Buy analyst consensus rating and an average price target of $206.14, implying a 39.05% upside potential from the current levels. The company's P/E of 19.82x reflects a 29.5% discount to the Technology sector's median of 28.10. Delta Air Lines (DAL) – This major American airline provides domestic and international passenger and cargo services. Its average price target of $67.50 implies a 14.93% upside potential from the current levels. DAL stock has a Strong Buy consensus rating. Trading at a P/E of 8.48x, the company is valued 66.1% below the Industrial sector's median multiple of 25.00. Post Holdings (POST) – This consumer packaged goods company is known for its branded and private-label foods. It has a Strong Buy analyst consensus rating and an average price target of $127.70, implying a 17.73% upside potential from the current levels. With a P/E ratio of 18.33x, the stock is priced at an 18.1% discount to the Consumer Defensive sector's median of 22.38. What Is TipRanks' Smart Value Newsletter? TipRanks' Smart Value Newsletter helps investors identify high-potential value stocks with strong fundamentals and long-term growth potential, based on TipRanks' data and analysis. The newsletter, published weekly, includes macroeconomic, market-wide, and company-specific analysis to help investors understand the trends that affect value investing.
Yahoo
05-08-2025
- Yahoo
Sabra (SBRA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended June 2025, Sabra Healthcare (SBRA) reported revenue of $189.15 million, up 7.4% over the same period last year. EPS came in at $0.38, compared to $0.10 in the year-ago quarter. The reported revenue represents a surprise of +1.98% over the Zacks Consensus Estimate of $185.47 million. With the consensus EPS estimate being $0.37, the EPS surprise was +2.7%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Sabra performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- Interest and other income: $10.34 million versus $10.03 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +13.6% change. Revenues- Rental and related revenues: $99.82 million versus $95.9 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +0.7% change. Revenues- Resident fees and services: $78.99 million compared to the $78.6 million average estimate based on two analysts. The reported number represents a change of +16.3% year over year. Net Earnings Per Share (Diluted): $0.27 compared to the $0.17 average estimate based on three analysts. View all Key Company Metrics for Sabra here>>> Shares of Sabra have returned -1.8% over the past month versus the Zacks S&P 500 composite's +0.6% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Sabra Healthcare REIT, Inc. (SBRA) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
22-07-2025
- Business Wire
Sabra Health Care REIT, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call
TUSTIN, Calif.--(BUSINESS WIRE)-- Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2025 second quarter earnings release on August 4, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 second quarter results will be held on Tuesday, August 5th at 10:00 a.m. Pacific Time. Share A conference call with a simultaneous webcast to discuss the 2025 second quarter results will be held on Tuesday, August 5 th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is A digital replay of the call will be available on our website at About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.
